Home › Funds › CANADA LIFE ASSURANCE Co › AZN

CANADA LIFE ASSURANCE Co position in AZN

ASTRAZENECA PLC · Health Care

CANADA LIFE ASSURANCE Co reported holding 1,460,001 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$238.0M, representing 0.39% of its reported portfolio and ranking #43 among its reported holdings. CANADA LIFE ASSURANCE Co has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.46M sh
Reported value held$237.97M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CANADA LIFE ASSURANCE Co's AZN position evolved

CANADA LIFE ASSURANCE Co first disclosed a stake in AZN in Q3 2023 at 1,060 shares (US$72K). The position peaked in Q1 2026 at 1,521,866 shares, worth US$295.8M. Across 13 filings, CANADA LIFE ASSURANCE Co increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,460,001 shares valued at US$238.0M — a reduction of -66,362 shares quarter over quarter.. Notable position changes include a 66% trim in Q4 2023 (shares rose 2% over the following quarter), a 104% increase in Q4 2025 (shares rose 8% over the following quarter), a 61117% increase in Q1 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.06K $72.00K New
Q4 2023 360 $24.00K Reduce
Q1 2024 506 $34.00K Add
Q2 2024 789 $62.00K Add
Q3 2024 1.05K $82.00K Add
Q4 2024 742 $49.00K Reduce
Q1 2025 905 $67.00K Add
Q2 2025 981 $69.00K Add
Q3 2025 1.22K $90.00K Add
Q4 2025 2.49K $229.00K Add
Q1 2026 1.52M $295.78M Add
Q2 2026 1.53M $285.24M Hold
Q3 2026 1.46M $237.97M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 65 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has CANADA LIFE ASSURANCE Co held AZN?

CANADA LIFE ASSURANCE Co has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CANADA LIFE ASSURANCE Co's current position in AZN?

As of Q3 2026, CANADA LIFE ASSURANCE Co holds 1.46M shares of AZN (ASTRAZENECA PLC), valued at $237.97M, representing 0.39% of its reported portfolio and ranking #43.

Has CANADA LIFE ASSURANCE Co been buying or selling AZN?

In the latest 13F filing (Q3 2026), CANADA LIFE ASSURANCE Co reduced its position in AZN. The position peaked in Q1 2026 at 1.52M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.